News & Blog

Tag Archives: Treatment

Glossary Blog, June 2018: Pivotal Clinical Trial

Pivotal Clinical Trial: A clinical trial or study intended to provide evidence for a new treatment approval by the United States Food & Drug Administration (FDA) This month we take a quick look at term that’s used in the field of biomedical research and drug development, that has both a figurative and an official technical/literal […]

Potential Brain Tumor Treatments Entering the Pivotal Phase of Evaluation – June 2018

A large, randomized, controlled Phase III clinical trial is traditionally the last, pivotal step in the evaluation of a potential new medicine before it is approved for use by all patients with the indicated disease. A year ago, the NBTS staff conducted and published a review of all the Phase III clinical trials for glioblastoma […]

Public Policy and Advocacy Updates From May 2018

Below are highlights of news and developments in the brain tumor advocacy and public policy, compiled by NBTS Research & Advocacy Manager, Kacey Troy Ribnik, and Director of Advocacy, Lainey Titus Samant: Brain Tumor Awareness Month (BTAM) 2018 was a very busy, productive, and successful month for the NBTS public policy advocacy program, all our wonderful volunteer advocates […]

Share